Trials / Recruiting
RecruitingNCT05326750
Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Kuopio University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.
Detailed description
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Gamma tACS (40 Hz) over the superior parietal cortex | Single session of gamma tACS (40 Hz) over the superior parietal cortex |
Timeline
- Start date
- 2022-11-21
- Primary completion
- 2032-07-01
- Completion
- 2032-07-01
- First posted
- 2022-04-14
- Last updated
- 2025-09-03
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT05326750. Inclusion in this directory is not an endorsement.